TP53 and neoplasm: While tumor-associated p53 mutant proteins lose most, but not necessarily all, of their ability to bind to the consensus DNA binding sequences recognized by WT p53 (Ludwig et al. 1996; Kato et al. 2003), they can acquire the ability to bind different promoters and so directly regulate new transcriptional programs (Dell'Orso et al. 2011).